Erythrocyte Sedimentation Rate (ESR) Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
Transparency Market Research presents this most up-to-date research on "Erythrocyte Sedimentation Rate (ESR) Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024" Erythrocyte sedimentation rate (ESR) can be defined as the rate at which red blood cells or erythrocytes sediment in a period of one hour. ESR is usually measured in millimeter per hour (mm/hr) and a value above 100 mm/hr indicates a disease condition, such as a disease that causes inflammation, active infection, cancer, heart disease, kidney disease, blood disease, diabetes, and collagen vascular disease. However, ESR is a non-specific test for inflammation and is used in conjunction with other tests such as C-reactive protein. Normal ESR result does not rule out the possibility of inflammation. Similarly, an elevated ESR without any symptoms of the disease does not aid in making any medical decision. ESR analyzers are devices employed to measure the sedimentation rate of erythrocytes for an accurate reading. Automated ESR analyzers need to comply with the 2011-published Clinical and Laboratory Standards Institute (CLSI) guidelines for measuring ESR. The analyzer works on the basic principle of Westergren’s method followed to determine ESR. The ESR analyzers market can be segmented based on modality, end-user, and region. In terms of modality, the market can be segmented into automatic analyzers, semi-automatic analyzers, and manual analyzers. Based on end-user, the ESR analyzers market can be segmented into hospitals, diagnostic laboratories, and academic institutions. In terms of region, the ESR analyzers market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. ESR is one of the basic hematology tests performed to identify various disease conditions, which would contribute to the growth of the ESR analyzers market. Technological upgrades leading to the development of automated ESR analyzers from manual ESR analyzers would also contribute to the growth of the market. In addition, the increasing number of infections leading to various health hazards would contribute to the rising number of ESR tests, which in turn would drive the ESR analyzers market in the near future. However, the non-specificity of the tests and the necessity for other tests to be performed to confirm the diseased condition could have a negative impact on the ESR analyzers market, as demand for specific tests increases. Furthermore, false negative results of ESR due to the effect of drugs such as oral contraceptives, dextran, methyldopa, penicillamine